FDA / 2026

Drugs@FDA database

Drugs@FDA database — U.S. FDA (2026), cited in PeptideAgent's Sermorelin evidence record.

Open original source

SOURCE METADATA

What this record represents.

Publisher
U.S. FDA
Evidence type
FDA
Publication year
2026
Source ID
fda-drugs

WHERE THIS IS CITED

Connected evidence records.

SermorelinPeptide analog · Growth Hormone